Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Response to Letter to Editor re: “Screening for pulmonary hypertension in preterm infants—not ready for prime time”

Journal of Perinatology volume 38, pages 1711–1713 (2018)Cite this article

Subjects

Dear Editor,

We appreciate the comments in the letter to the editor in response to our recent commentary on screening for pulmonary hypertension (PH) in preterm infants [1]. It appears that the authors of this letter fundamentally agree with the content of our commentary, while arguing for a pragmatic approach to the management of infants with bronchopulmonary dysplasia (BPD) who are either at high risk for PH, or have clinical manifestations of PH. Below are our responses to these authors’ comments.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Suresh G, King BC, Jain SK. Screening for pulmonary hypertension in preterm infants-not ready for prime time. J Perinatol. 2018;38:206–10.

    Article  Google Scholar 

  2. Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, et al. Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society. Circulation. 2015;132:2037–99.

    Article  Google Scholar 

  3. Krishnan U, Feinstein JA, Adatia I, Austin ED, Mullen MP, Hopper RK, et al. Evaluation and management of pulmonary hypertension in children with bronchopulmonary dysplasia. J Pediatr. 2017;188:24–34 e21.

    Article  Google Scholar 

  4. Merelle ME, Schouten JP, Gerritsen J, Dankert-Roelse JE. Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients. Eur Respir J. 2001;18:306–15.

    Article  CAS  Google Scholar 

  5. Schunemann H, Brożek J, Guyatt G, Oxman A, editors. GRADE Working Group: GRADE handbook for grading quality of evidence and strength of recommendations. https://gdtgradeproorg/app/handbook/handbookhtml [updated October 2013]; Accessed May 2018.

  6. Straus SE, Richardson WS, Glasziou P, Haynes RB. Evidence-based Medicine: How to Practice and Teach it. Churchill Livingstone, 4th edition; 2011.

  7. Cummings JJ, D’Eugenio DB, Gross SJ. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med. 1989;320:1505–10.

    Article  CAS  Google Scholar 

  8. Ratzan SC. The plural of anecdote is not evidence. J Health Commun. 2002;7:169–70.

    Article  Google Scholar 

  9. Balakrishnan M, Raghavan A, Suresh GK. Eliminating undesirable variation in neonatal practice: balancing standardization and customization. Clin Perinatol. 2017;44:529–40.

    Article  Google Scholar 

  10. Backes CH, Reagan PB, Smith CV, Jadcherla SR, Slaughter JL. Sildenafil treatment of infants with bronchopulmonary dysplasia-associated pulmonary hypertension. Hosp Pediatr. 2016;6:27–33.

    Article  Google Scholar 

  11. Kadmon G, Schiller O, Dagan T, Bruckheimer E, Birk E, Schonfeld T. Pulmonary hypertension specific treatment in infants with bronchopulmonary dysplasia. Pediatr Pulmonol. 2017;52:77–83.

    Article  Google Scholar 

  12. Zaidi AN, Dettorre MD, Ceneviva GD, Thomas NJ. Epoprostenol and home mechanical ventilation for pulmonary hypertension associated with chronic lung disease. Pediatr Pulmonol. 2005;40:265–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Baylor College of Medicine, Section Head and Service Chief of Neonatology, Texas Children’s Hospital, 6621 Fannin, Suite W6104, Houston, TX, 77030, USA

    Gautham Suresh

  2. Department of Pediatrics, Baylor College of Medicine, Texas Children’s Hospital, 6621 Fannin, Suite W6104, Houston, TX, 77030, USA

    Brian King

  3. Department of Pediatrics, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555, USA

    Sunil K. Jain

Authors
  1. Gautham Suresh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brian King
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sunil K. Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sunil K. Jain.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Suresh, G., King, B. & Jain, S.K. Response to Letter to Editor re: “Screening for pulmonary hypertension in preterm infants—not ready for prime time”. J Perinatol 38, 1711–1713 (2018). https://doi.org/10.1038/s41372-018-0194-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-018-0194-8

Search

Advanced search

Quick links